company background image
BTMD

biote NasdaqGM:BTMD Stock Report

Last Price

US$4.06

Market Cap

US$231.3m

7D

6.3%

1Y

-58.3%

Updated

29 Nov, 2022

Data

Company Financials +

biote Corp. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for biote
Historical stock prices
Current Share PriceUS$4.06
52 Week HighUS$10.53
52 Week LowUS$2.00
Beta0
1 Month Change-7.94%
3 Month Change-7.73%
1 Year Change-58.27%
3 Year Changen/a
5 Year Changen/a
Change since IPO-59.60%

Recent News & Updates

biote initiated as a buy at Truist on leadership in hormone optimization; sees 138% upside

Sep 27

Biote partners with IMAC Holdings

Sep 07

Recent updates

Shareholder Returns

BTMDUS PharmaceuticalsUS Market
7D6.3%0.5%-0.9%
1Y-58.3%13.0%-18.9%

Return vs Industry: BTMD underperformed the US Pharmaceuticals industry which returned 12.2% over the past year.

Return vs Market: BTMD underperformed the US Market which returned -20.5% over the past year.

Price Volatility

Is BTMD's price volatile compared to industry and market?
BTMD volatility
BTMD Average Weekly Movement6.0%
Pharmaceuticals Industry Average Movement11.0%
Market Average Movement7.4%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market3.3%

Stable Share Price: BTMD is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: BTMD's weekly volatility has decreased from 12% to 6% over the past year.

About the Company

FoundedEmployeesCEOWebsite
2011n/aTerry Weberhttps://biote.com

biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient’s hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women.

biote Corp. Fundamentals Summary

How do biote's earnings and revenue compare to its market cap?
BTMD fundamental statistics
Market CapUS$231.30m
Earnings (TTM)US$107.70m
Revenue (TTM)US$158.01m

2.1x

P/E Ratio

1.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
BTMD income statement (TTM)
RevenueUS$158.01m
Cost of RevenueUS$52.68m
Gross ProfitUS$105.33m
Other Expenses-US$2.37m
EarningsUS$107.70m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)1.89
Gross Margin66.66%
Net Profit Margin68.16%
Debt/Equity Ratio-108.9%

How did BTMD perform over the long term?

See historical performance and comparison